Zydus Lifesciences Ltd.

NSE: ZYDUSLIFE | BSE: 532321 | ISIN: INE010B01027 | Industry: Pharmaceuticals
| Mid-range Performer
979.6000 6.65 (0.68%)
NSE Jul 11, 2025 15:31 PM
Volume: 921.0K
 

979.60
0.68%
ICICI Securities Limited
Zydus Lifesciences’ (Zydus) Q4FY25 revenue gained with healthy traction in US (+20%), domestic branded formulation (+10.7%) and its consumer business (+17.1%).
Zydus Lifesciences L.. has an average target of 988.60 from 5 brokers.
More from Zydus Lifesciences Ltd.
Recommended